Selective action of acute systemic clozapine on acetylcholine release in the rat prefrontal cortex by reference to the nucleus accumbens and striatum

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 1, 1997, Pages 582-588

  Parada, Marco A ^a,b   Hernandez, L ^a   De Parada, M Puig ^a   Rada, P ^a   Murzi, E ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b Department of Physiology ^*  (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CLOZAPINE; TETRODOTOXIN;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; EXTRAPYRAMIDAL SYMPTOM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REGRESSION ANALYSIS;

ACETYLCHOLINE; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CORPUS STRIATUM; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; TETRODOTOXIN;

EID: 0031007902     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. ABOOD, L. G. AND BIEL, J. H.: Anticholinergic psychotomimetic agents. Int. Rev. Neurobiol. 4: 217-273, 1962.
2. AJIMA, A., YAMAGUCHI, T. AND KATO, T.: Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions. Brain Res. 518: 193-198, 1990.
3. AYD, F. J.: Neuroleptics and extrapyramidal reactions in psychiatric patients. In Systeme Extrapyramidal et Neuroleptiques, ed. by J. M. Bordelau, pp. 355-363, Editions Psychiatriques, Montreal, 1961.
4. BORDELAIS, A. J. AND DEUTCH, A. Y.: The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study. Cereb. Cortex 4: 69-77, 1994.
5. BRUNE, G. G., MORPURGO, C., BEILKUS, A., KOBAYASHI, T., TOURLENTES, T. T. AND HIMWICH, H. E.: Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. I. Treatment with trifluoperazine singly and in combination with trihexyphenidyl. Comp. Psychiatr. 3: 227-234, 1962.
6. CHIODO, L. A. AND BUNNEY, B. S.: Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 3: 1607-1619, 1983.
7. CHIODO, L. A. AND BUNNEY, B. S.: Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J. Neurosci. 5: 2539-2544, 1985.
8. CONSOLO, S., GIROTTI, P., RUSSI, G. AND DICHIARA, G.: Endogenous dopamine facilitates striatal in vivo acetylcholine release by acting on D1 receptors localized in the striatum. J. Neurochem. 59: 1555-1557, 1992.
9. CONSOLO, S., WU, C. F. AND FUSI, R.: D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum. J. Pharmacol. Exp. Ther. 242: 300-305, 1987.
10. CREESE, I., BURT, D. R. AND SNYDER, S. H.: Dopamine receptor binding predicts clinical and pharmacological potencies of antipsychotic drugs. Science 192: 481-483, 1976.
11. DALY, D. A. AND MOGHADDAM, B.: Actions of clozapine and haloperidol on the extracellular levels of excitatory aminoacids in the prefrontal cortex and striatum of conscious rats. Neurosci. Lett. 152: 61-64, 1993.
12. DAMSMA, G., DE BOER, P., WESTERINK, B. H. C. AND FIBIGER, H. C.; Dopaminergic regulation of striatal cholinergic interneurons: an in vivo microdialysis study. Naunyn-Schmiedebrg Arch. Pharmacol. 342: 523-527, 1990a.
13. DAMSMA, G., THAM, C.-S., ROBERTSON, G. S. AND FIBIGER, H. C.: Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. Eur. J. Pharmacol. 186: 335-338, 1990b.
14. DAWSON, V. L., DAWSON, T. M., FILLOUX, F. M. AND WAMSLEY, J. K.: Evidence for dopamine D-2 receptors on cholinergic interneurons in the rat caudateputamen. Life Sci. 42: 1933-1939, 1988.
15. DAY, J. AND FIBIGER, H. C.: Dopaminergic regulation of cortical acetylcholine release. Synapse 12: 281-286, 1992.
16. DAY, J. AND FIBIGER, H. C.: Dopaminergic regulation of cortical acetylcholine release: effects of dopamine receptor agonists. Neuroscience 54: 643-648, 1993.
17. DE BOER, P. AND ABERCROMBIE, E. D.: Physiological release of striatal acetylcholine in vivo: Modulation by D1 and D2 dopamine receptors subtypes. J. Pharmacol. Exp. Ther. 277: 775-783, 1996.
18. DE BOER, P., ABERCROMBIE, E. D., HEERINGA, M. AND WESTERINK, B. H. C.: Differential effect of systemic administration of bromocriptine and 1-DOPA on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats. Brain Res. 608: 198-203, 1993.
19. DE BOER, P., DAMSMA, G., FIBIGER, H. C., TIMMERMAN, W., DE VRIES, J. B. AND WESTERINK, B. H. C.: Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis. Naunyn-Schmiedeber Arch. Pharmacol. 342: 528-534, 1990.
20. DE BOER, P., DAMSMA, G., SCHRAM, Q., STOOF, J. C., ZAAGSMA, J. AND WESTERINK, B. H. C.: The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval. Naunyn-Schmiedeberg Arch. Pharmacol. 345: 144-152, 1992.
21. FISHER, C. M.: Visual hallucinations on eye closure associated with atropine toxicity. A neurological analysis and comparison with other visual hallucinations. Can. J. Neurol. Sci. 18: 18-27, 1991.
22. GERLACH, J. AND SIMMELSGARD, H.: Tardive dyskinesia during and following treatment with haloperidol, haloperidol and biperiden, thioridazine and clozapine. Psychopharmacology 59: 105-112, 1978.
23. GERSHON, S. AND OLARIU, J.: A new psychotomimetic: Its antagonism by tetrahydroaminoacridine and its comparison with LSD, mescaline, and sernyl. J. Neuropsychiatr. 1: 182-293, 1960.
24. HERMAN, E. AND PLEASURE, H.: Clinical evaluation of thioridazine and chlorpromazine in chronic schizophrenia. Dis. Nervous System 24: 54-59, 1963.
25. HERNANDEZ, L. AND HOEBEL, B. G.: Chronic clozapine selectively decreases prefrontal cortex dopamine as shown by simultaneous cortical, accumbens, and striatal microdialysis in freely moving rats. Pharmacol. Biochem. Behav. 52: 581-589, 1995.
26. HERNANDEZ, L., STANLEY, B. G. AND HOEBEL, B. G.: A small, removable microdialysis probe. Life Sci. 39: 2629-2637, 1986.
27. IMPERATO, A., OBINU, M. C., CASU, M. A., MASCIA, M. S., DAZZI, L. AND GESSA, G. L.: Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors. J. Pharmacol. Exp. Ther. 266: 557-562, 1993.
28. IMPERATO, A., OBINU, M. C., DAZZI, L. AND GESSA, G. L.: Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo? Eur. J. Pharmacol. 251: 271-279, 1994.
29. KUBOTA, Y., INAGAKI, S., SHIMADA, S., KITO, S., ECKENSTEIN, F. AND TOHYAMA, M.: Neostriatal cholinergic neurons receive direct synaptic imputs from dopaminergic axons. Brain Res. 413: 179-184, 1987.
30. LAHTI, R. A., EVANS, D. L., STRATMAN, N. C. AND FIGUR, L. M.: Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications. Eur. J. Pharmacol. 236: 483-486, 1993.
31. LE MOINE, C., TISON, F. AND BLOCH, B.: D-2 dopamine receptor gene expression by cholinergic neurons in rat striatum. Neurosci. Lett. 117: 248-252, 1990.
32. LJUNGBERG, T. AND UNGERSTEDT, U.: Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action. Psychopharmacology 56: 239-247, 1978.
33. LJUNGBERG, T. AND UNGERSTEDT, U.: A rapid and simple behavioral screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs. Pharmacol. Biochem. Behav. 23: 479-485, 1985.
34. MOGHADDAM, B. AND BUNNEY, B. S.: Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry 14: S51-S57, 1990.
35. MOORE, S. AND KENYON, P.: Atypical antipsychotics, clozapine and sulpiride do not antagonize amphetamine-induced stereotyped locomotion. Psychopharmacology 114: 123-130, 1994.
36. O'MALLEY, K. L., HAEMON, S., TANG, L. AND TODD, R. D.: The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol. 4: 137-146, 1992.
37. PARADA, M. A., PUIG DE PARADA, M. AND HOEBEL, B. G.: A new triple channel swivel for fluid delivery in the range of intracranial (10 nl and intravenous (100 μl) self-administration volumes and also suitable for microdialysis. J. Neurosci. Methods 54: 1-8, 19941 a).
38. PARADA, M. A., PUIG DE PARADA, M., RADA, P., HERNANDEZ, L. AND HOEBEL B. G.: Sulpiride is self-injected in the Lateral Hypothalamus (LH) where it releases acetylcholine (ACh) and induces also dopamine (DA) release in the nucleus accumbens. Soc. Neurosci. Abstr. 20: 226, 1994(b).
39. PARADA, M. A., PUIG DE PARADA, M., HERNANDEZ, L. AND MURZI, E.: A practical method for simultaneous multiple intracerebral implantation in rats. Neurosci. Protoc. 1997, Submitted.
40. PEHEK, E. A. AND YAMAMOTO, B. K.: Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J. Neurochem. 63: 2118-2124, 1994.
41. PFEIFFER, C. C. AND JENNEY, E. H.: The inhibition of conditional response and counter action of schizophrenia by muscarinic stimulation of the brain. Ann. N Y. Acad. Sci. 66: 753-764, 1957.
42. RADA, P., MARK, G. P. AND HOEBEL, B. G.: In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: I. Inhibition by serotonin. Brain Res. 619: 98-104, 1993a.
43. RADA, P., MARK, G. P. AND HOEBEL, B. G.: In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: II. Inhibition by &-aminobutyric acid. Brain Res. 619: 105-110, 1993b.
44. RAMA RAO, V. A., BAILEY, J., AND BISHOP, M.: A clinical and pharmacodynamic evaluation of sulpiride. Psychopharmacology 73: 77-80, 1981.
45. ROBERTSON, G. S., THAM, C.-S., WILSON, C., JAKUBOVIC, A. AND FIBIGER, H. C.: In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. J. Pharmacol. Exp. Ther. 264: 1344-1351, 1993.
46. RUSSELL, V. A., ALLIN, R., LAMM, M. C. L. AND TALJAARD, J. J. F.: Increased dopamine D2 receptor-mediated inhibition of [14C]acetylcholine release in the dorsomedial part of the nucleus accumbens. Neurochem. Res. 14: 877-881, 1989.
47. SCHWARTZ, J.-C., GIROS, B., MARTRES, M.-P. AND SOKOLOFF, P.: Multiple dopamine receptors as molecular targets for antipsychotics. In New Generation of Antipsychotic Drugs: Novel Mechanisms of Action, ed. by N. Brunello, J. Mendlewicz and G. Racagni, pp. 1-14, Int. Acad. Biomed. Drug Res., Basel. Switzerland, 1993.
48. SEEMAN, P.: Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7: 261-284, 1992.
49. SEEMAN, P., GUAN, H.-C. AND VAN TOL, H. H. M.: Dopamine D4 receptors elevated in schizophrenia. Nature 365: 441-445, 1993.
50. SEEMAN, P. AND LEE, T.: Antipsychotic drugs: direct correlation between clinical potencies and presynaptic actions on dopamine neurons. Science 188: 1217-1219, 1975.
51. SINGH, M. M. AND KAY, S. R.: Therapeutic reversal with benztropine in schizuphrenics. J. Nerv. Mental Dis. 169: 258-266, 1975.
52. SINGH, M. M. AND KAY, S. R.: Pharmacology of central cholinergic mechanisms and schizophrenic disorders. In Central Cholinergic Mechanisms and Adaptive Functions, ed. by M. M. Singh, D. M. Warburton and H. Lal, pp. 247-308, Plenum, New York, 1985.
53. SNYDKR, S. H., BANKRJEE, S. P., YAMAMURA, H. I. AND GREENBER, D.: Drugs, neurotransmitters and schizophrenia. Science 184: 1243-1253, 1974.
54. SNYDER, S. H., CREESE, I. AND BURT, D. R.: The brain's dopamine receptor: labeling with (H3)dopamine and (H3)haloperidol. Psychopharmacol. Commun. 1: 663-673, 1975.
55. STOOF, J. C., DRUCKARCH, B., DE BOER, P., WESTERINK, B. H. C. AND GROENFWEGEN, H. J.: Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience 47: 755-770, 1992.
56. SZECHTMAN, H., EILAM, D., TEITELAUM, P. AND GOLANI, I.: A different look at measurement and interpretation of stereotyped behaviour. Psychobiology 16: 164-173, 1988.
57. TSCHANZ, J. T. AND REBEC, G. V.: Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy. Pharmacol. Biochem. Behav. 31: 519-522, 1989.
58. VAN TOL, H. H. M., BUNZOW, J. R., GUAN, H.-C., SUNAHARA, R. K., SEEMAN, P., NIZNIK, H. B. AND CIVELLI, O.: Cloning of a human dopamine D4 receptor gene with high affinity for the antipsychotic clozapine. Nature 350: 614-619, 1991.
59. WEDZONY, K., LIMBERGER, N., SPÄTH, L., WICHMANN, T. AND STARKE, K.: Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors. Naunyn-Schmiedeberg Arch. Pharmacol. 338: 250-255, 1988.
60. WHITE, F. J. AND WANG, R. Y.: Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221: 1054-1056, 1983.
61. YAMAMOTO, B. K. AND COOPERMAN, M. A.: Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci. 14: 4159-4166, 1994.
62. YEOMANS, J. S.: Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic Psychosis and schizophrenia. Neuropsychopharmacology 12: 3-16, 1995.
63. YOUNGREN, K. D., MOGHADDAM, B., BUNNEY, B. S. AND ROTH, R. H.: Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment. 165: 41-44, 1994.